In this video A/Prof. Nick Murray presents a case for discussion on CDK 4/5 inhibitor sequencing considerations and backbone therapy options in advanced breast cancer.

A/Prof. Nick Murray is Consultant Medical Oncologist at the Royal Adelaide Hospital.

(22 minutes)

This video is part of a series of case study discussions on considerations in the use of CDK 4/6 inhibitors in advanced breast cancer, moderated by Dr Rick de Boer, Medical Oncologist at Peter MacCallum Cancer Centre, Epworth-Freemasons and St Vincent’s Private Hospital, Melbourne.

Other videos in the series include:

• Choice of CDK 4/6 inhibitor (case presented by Dr Nicole Potasz)
• The role of real world evidence in clinical decision making (case presented by Dr Bianca Devitt)

These videos were created independently by the limbic. All case studies were developed by the presenters and views are those of the presenters alone.

Thank you to Pfizer for providing a non-restrictive educational grant that made this project possible.